SL
NVO

Salomon & Ludwin’s Novo Nordisk NVO Stock Holding History

Salomon & Ludwin’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.8K Buy
2,673
+1,488
+126% +$70.5K 0.01% 253
2025
Q4 		$65.3K Sell
1,185
-300
-20% -$15.3K 0.01% 335
2025
Q3 		$88.6K Buy
1,485
+999
+206% +$58.5K 0.01% 246
2025
Q2 		$33.9K Buy
486
+26
+6% +$1.77K ﹤0.01% 312
2025
Q1 		$31.9K Sell
460
-22
-5% -$1.82K ﹤0.01% 305
2024
Q4 		$41.5K Hold
482
– – ﹤0.01% 263
2024
Q3 		$57.4K Hold
482
– – 0.01% 243
2024
Q2 		$68.8K Sell
482
-130
-21% -$17.2K 0.01% 225
2024
Q1 		$78.6K Buy
612
+202
+49% +$24K 0.01% 286
2023
Q4 		$37.3K Hold
410
– – ﹤0.01% 339
2023
Q3 		$37.3K Buy
+410
New +$36.1K ﹤0.01% 339

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Salomon & Ludwin's NVO Position: Q1 2026 in Review

Salomon & Ludwin increased its Novo Nordisk (NVO) stake by 126% in Q1 2026, buying an estimated $70.5K and bringing the position to 2,673 shares worth $98.8K. The position accounts for 0.01% of the portfolio, ranked #253.

Salomon & Ludwin first reported a position in NVO in Q3 2023 and has held it in 11 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Salomon & Ludwin held 2,673 shares of Novo Nordisk worth $98.8K as of Q1 2026.
  • Salomon & Ludwin bought 1,488 Novo Nordisk shares in Q1 2026, an estimated $70.5K.
  • Novo Nordisk made up 0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #253 holding.
  • Salomon & Ludwin first reported a position in Novo Nordisk in Q3 2023 and has held it in 11 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.